SK-BR-3 cells

Cat# C0006007

Size : OneFrozenvial


References for SK-BR-3 cells:

1. Brockhoff, G., Heckel, B., Schmidt-Bruecken, E., Plander, M., Hofstaedter, F., Vollmann, A., and Diermeier, S. Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation. Cell Prolif, 40: 488-507, 2007.

2. Choi, E. J. and Kim, G. H. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem, 20: 285-290, 2009.

3. Hill, A. A., LaPan, P., Li, Y., and Haney, S. Impact of image segmentation on high-content screening data quality for SK-BR-3 cells. BMC Bioinformatics, 8: 340, 2007.

4. Koster, F., Felberbaum, R., Finas, D., Wunsch, K., Schulz, C., Diedrich, K., and Hauser, C. Progesterone and estradiol enhance lipid mediated transfection of Sk-Br-3 mammalian cancer cells. Int J Mol Med, 9: 617-620, 2002.

5. Lin, Y. J., Huang, Y. H., Zhen, Y. Z., Liu, X. J., and Zhen, Y. S. [Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway]. Yao Xue Xue Bao, 43: 1099-1105, 2008.

6. Manfroid, I., Van de Weerdt, C., Baudhuin, A., Martial, J. A., and Muller, M. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element. Mol Cell Endocrinol, 229: 127-139, 2005.

Certificate of Analysis/MSDS is available upon request with lot number

You might also be interested by the following products:



Cat#
Description
Cond.
Price Bef. VAT
CM-0211
Discontinued
-
800100
 100milliliter